Standard InChI: InChI=1S/C18H18N2O2/c1-13(21)20-18(15-8-10-16(22-2)11-9-15)12-17(19-20)14-6-4-3-5-7-14/h3-11,18H,12H2,1-2H3
Standard InChI Key: ZPDSCMQRJLPXDN-UHFFFAOYSA-N
Associated Targets(Human)
HEp-2 3859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
IMR-32 1082 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
OVCAR 348 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
PC-3 62116 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Bacillus subtilis 32866 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Enterococcus faecalis 29875 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Pseudomonas aeruginosa 123386 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Escherichia coli 133304 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Enterobacter cloacae 7976 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Xanthine dehydrogenase 2296 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cathepsin B 109 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cathepsin H 102 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 294.35
Molecular Weight (Monoisotopic): 294.1368
AlogP: 3.39
#Rotatable Bonds: 3
Polar Surface Area: 41.90
Molecular Species: NEUTRAL
HBA: 3
HBD: 0
#RO5 Violations: 0
HBA (Lipinski): 4
HBD (Lipinski): 0
#RO5 Violations (Lipinski): 0
CX Acidic pKa:
CX Basic pKa: 1.32
CX LogP: 2.74
CX LogD: 2.74
Aromatic Rings: 2
Heavy Atoms: 22
QED Weighted: 0.87
Np Likeness Score: -1.08
References
1.Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.. (2010) Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors., 20 (15):[PMID:20594840][10.1016/j.bmcl.2010.05.105]
2.Nepali K, Singh G, Turan A, Agarwal A, Sapra S, Kumar R, Banerjee UC, Verma PK, Satti NK, Gupta MK, Suri OP, Dhar KL.. (2011) A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors., 19 (6):[PMID:21353569][10.1016/j.bmc.2011.01.058]
3.Nepali K, Kadian K, Ojha R, Dhiman R, Garg A, Singh G, Buddhiraja A, Bedi PMS, Dhar KL. (2012) Effect of ring A and ring B substitution on the cytotoxic potential of pyrazole tethered chalcones, 21 (10):[10.1007/s00044-011-9824-9]
4.Raghav N, Singh M.. (2014) SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H., 22 (15):[PMID:24913985][10.1016/j.bmc.2014.05.037]